Chinese University of Hong Kong
Hong Kong
Location status: Recruiting
Location contact
Thomas Wai Hong LEUNG, FRCP
CONTACT
Tiffany CHUNG
CONTACT
NCT Number: NCT03295773
This study is to elucidate the morphologic evolution and remodeling of ICAD under stringent control of cardiovascular risk factors.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Hong Kong
Location status: Recruiting
Thomas Wai Hong LEUNG, FRCP
CONTACT
Tiffany CHUNG
CONTACT
The investigator has conducted extensive research on ICAD by transcranial Doppler ultrasound, CT angiography and perfusion studies, magnetic resonance imaging (MRI) and digital subtraction angiography (DSA) respectively. Currently, the investigator applied 3-dimensional rotational angiogram (3DRA), a selective intra-arterial catheter-based imaging technique that had a superior spatial resolution compared with CT, MRI or DSA in depicting minute (<3mm) angio-architecture. Through 3DRA, the investigator could appreciate the ICAD patho-anatomy from a near-infinite number of planes, analyzing the stroke mechanisms and morphological changes with much improved precision. A neuro-radiologist and a stroke neurologist blind to time sequence will measure the geometric parameters and the luminal narrowing by WASID method.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient with any of the following conditions would be excluded:
Time frame: Dec, 2019
The 3DRA images (the disparity in morphological attributes, including surface outline, angulations, plaque volume and distribution) of the patients in pre and post 12 month follow-up would be compared.
Contact information is provided by the study sponsor or research team.
Chinese University of Hong Kong
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03291652
Arterial Occlusive Diseases, Arteriosclerosis
Hong Kong
View Trial DetailsNCT01819597
Arterial Occlusive Diseases, Arteriosclerosis
Los Angeles, California, United States
View Trial DetailsNCT06604117
Arterial Occlusive Diseases, Arteriosclerosis
Xicheng District, Beijing Municipality, China
View Trial DetailsNCT06541691
Arterial Occlusive Diseases, Arteriosclerosis
Tehran, Tehran Province, Iran
View Trial Details